
Khaite to open fifth US store in Los Angeles
The address chosen by the Khaite brand is an iconic Los Angeles store, located at the corner of Melrose Avenue and Melrose Place, recognizable by its ivy-covered building, formerly occupied by the Marc Jacobs boutique and the Gucci Salon store. Opened in April 2023, the ultra-luxury concept initiated by the Italian fashion house Gucci 'designed to offer the most personal universe possible, and intended for a clientele invited exclusively by appointment' will have lasted just two years.
With neighbors such as A.P.C, Isabel Marant, Balmain and Chloé, the New York-based Khaite brand confirms its recent ascendancy among modern luxury brands, and its promised retail expansion to a dozen boutiques by 2030.
Named designer of the year for women's ready-to-wear at the CFDA awards in 2022, Catherine Holstein, who has previously collaborated for Gap, Vera Wang, J.Crew and The Elder Statesman, has benefited in recent years from several key investors to ensure her expansion.
After the support of brand incubator Assembled Brands, its majority shareholder, the brand received in 2023 the backing of a new partner, Stripes, a New York-based private equity firm.
Renowned for its minimalist and effortless style, the Khaite brand will have five boutiques in the United States by the end of the year. A retail story which began in New York in 2023, when the brand opened its first boutique at 165 Mercer Street in Soho.
"To open our first store in Soho was a dream come true," said Holstein, at the store opening. 'Every element of Khaite is shaped by New York, and we set out to make this space a tribute to the cultural legacy of Soho. When I moved to New York twenty years ago, this block of Mercer was my entry point to the city, and Soho is where Khaite was born. Our first design studio was just down the street.'
The opening of a first boutique in Los Angeles looks to be in line with the subtle, minimalist design chosen for the other boutiques, like the design of the New York boutique entrusted to her architect husband, Griffin Frazen, and conceived around steel and concrete.
In September 2024, the brand added a second store at Highland Park Village, a premier open-air luxury shopping and dining destination in Dallas, home to such luxury brands as Akris, Alexander McQueen, Balmain, Chanel, Cartier, Dior, Fendi and Hermès.
This was followed at the end of January by a second boutique in New York located at 828 Madison Avenue, at the intersection of Madison Avenue and 69th Street. Following the brand's flagship located at 165 Mercer Street, Holstein partnered with Frazen for the design of the brand's uptown location. For this third space, the design drew inspiration from Japanese tatami mat principles, and used bronze and metal as key materials.
Finally, last March, Holstein signed its arrival on the West Coast with the opening of its first boutique in the famous South Coast Plaza luxury shopping destination. Another spectacularly designed concept, featuring an asymmetrical grid of sculptural columns that seem to pierce the ceiling.
As in other Khaite stores, the palette of materials at South Coast Plaza is deliberately austere - blackened steel, prefabricated concrete and smooth plaster - to create a backdrop that highlights the ready-to-wear collections.
'The overall effect is one of conscious withdrawal from the outside world, where architecture becomes an active participant in elevating the luxury retail experience" said Khaite's team.
Currently pregnant with her second child, Holstein will present her new spring/summer 2026 collection at New York Fashion week this June. She has been showing in New York since 2019.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fashion Network
2 hours ago
- Fashion Network
Zalando's Q2 GMV and revenue rise, e-tailer ups guidance after About You buy
That was helped by continued investment in customer experience and it expects this week's launch of its AI-driven discovery feed that it says will 'deliver even more personalised inspiration and boost organic customer engagement' to help it further in Q3. B2C growth in the second quarter was also supported by strong progress in its two other growth pillars, which are 'differentiation through quality and lifestyle expansion'. Its upgraded loyalty programme reached more than 10 million customers at the end of the quarter as it rolled out to more markets. It also delivered 'over proportional growth' in its Lounge, Designer, and Beauty propositions, 'making progress on building out more areas that address more lifestyle needs of customers, thus enabling Zalando to capture a higher share of customers' wallets'. Meanwhile Business-to-Business (B2B) maintained 'strong momentum, driven by double-digit growth in ZEOS Fulfilment'. The launch of a new Shopify application that connects Shopify merchants directly to the ZEOS platform was also key. B2B revenues increased 12.2% to €262 million. Adjusted EBIT was €11 million, with the margin increasing by 1.3 percentage points to 4.3%. And there's plenty of potential for this to rise. UK retailer Next is now leveraging Zalando's fulfilment infrastructure for its largest mainland Europe market, Germany, after already using ZFS for the majority of its Zalando-based business. In the second half, it will expand the collaboration to include its own webshop and additional European marketplace business. Finally, following the About You acquisition in July, the company has issued its first full-year 2025 guidance for the combined group. It expects annual GMV of €17.2 billion-€17.6 billion, revenue of €12.1 billion-€12.4 billion, and adjusted EBIT of €550 million-€600 million. Forecast GMV volumes up by 12%-15% will be a big step forward from the previously expected range of 4%-9%.


Fashion Network
4 hours ago
- Fashion Network
India accuses EU, US of double standard over Russian trade
India has sharply criticised the US and the European Union, saying it is being unfairly singled out by them over its Russian oil purchases when they both trade extensively with Moscow despite the war in Ukraine. India's criticism followed a renewed threat by US President Donald Trump on Monday to raise tariffs on goods from India over its Russian oil purchases, deepening the trade rift between the two countries. In a rare show of unity, Prime Minister Narendra Modi's Bharatiya Janata Party (BJP) and the main opposition Congress on Tuesday condemned Trump's repeated criticism of New Delhi. India's Foreign Ministry said in a statement issued late on Monday that "it is revealing that the very nations criticising India are themselves indulging in trade with Russia". The US embassy and the EU's delegation in New Delhi did not immediately respond to a request for comment. Both the US and EU have sharply scaled back their trade ties with Russia since it launched a full-scale invasion of Ukraine in February 2022. In 2021, Russia was the EU's fifth-largest trading partner, with goods exchange worth 258 billion euros, according to the EU executive European Commission. The sudden rift between India and the US has been deepening since July 31, when Trump announced a 25% tariff on Indian goods being shipped to the US and for the first time threatened unspecified penalties for buying Russian oil. India is one of the biggest buyers of crude from Russia, importing about 1.75 million barrels per day from January to June this year, up 1% from a year ago. India has said it does not support "unilateral sanctions" by the EU. Trade experts say Trump's tariff could badly hurt India's economy. Ajay Srivastava of the New Delhi-based Global Trade Research Initiative said he expected Indian goods exports to the US to fall 30% in the current fiscal year ending March 31, to 60.6 billion dollars from 86.5 billion dollars in the 2025 fiscal year. India's equity benchmarks fell after Trump's renewed threat of harsh tariffs on goods from India. Manish Tewari, a member of parliament and Congress leader, said Trump's "disparaging remarks hurt the dignity and self-respect of Indians". "The time has come to call out this constant bullying and hectoring," he added. BJP Vice President Baijayant Jay Panda quoted Henry Kissinger - the most powerful US diplomat of the Cold War era - in a post on X: "To be an enemy of America can be dangerous, but to be a friend is fatal."


Euronews
5 hours ago
- Euronews
Pfizer earnings strong despite Trump's new 'up to 250%' tariff threat
Pharmaceutical giant Pfizer reported better-than-expected quarterly results on Tuesday and improved its predictions for full-year profits, beating Wall Street expectations. The New York-based company reported second-quarter sales of $14.7 billion (€12.74bn) and earnings per share of $0.51 (€0.44). As of around 16.00 CEST, Pfizer shares were up over 4% at $24.58. "Our business is performing well and I'm pleased with the progress we achieved in the second quarter," chairman and CEO Albert Bourla said in a statement. "We continue to be actively engaged with policymakers as we navigate a complicated and rapidly evolving geopolitical environment while also remaining focused on advancing our business," Bourla continued. This despite several policies announced by the current US administration that could hurt drugmakers. In May, US President Donald Trump signed an executive order whereby pharmaceutical companies would be compelled to lower prices based on a "Most Favored Nation" policy. The price-slashing scheme seeks to ban drug companies from selling products in the US at prices above those in other developed countries. In Europe, the comparison becomes complex, as a significant portion pharmaceutical costs are covered by national healthcare or insurance systems, lowering prices for consumers. Experts warned at the time that this could slash their US revenues and affect availability. Even so, the president doubled down on his plans, sending letters last week to 17 drugmakers, calling for concrete steps to cut prices by 29 September. That includes agreeing to provide their full portfolio of existing medicines at no higher than European prices to every single Medicaid patient. On Tuesday, in an interview with CNBC, he announced that tariffs for pharmaceuticals and semiconductors would be coming in "next week". 'We'll be putting an initially small tariff on pharmaceuticals, but in one year, one-and-a-half years, maximum, it's going to go to 150% and then it's going to go to 250% because we want pharmaceuticals made in our country," he told CNBC.